Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - kevin+nash
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Secreted UBE3A for the Treatment of Neurological Disorders
Advantages: Novel vector, composition, and method of treating a neurological disorder with UBE3A deficiency. High fidelity to human Angelman syndrome. Facilitates comprehensive symptom representation for diverse treatment investigations. Allows innovative experiments for pioneering treatment development. Summary: Angelman...
Published: 1/2/2024
|
Inventor(s):
Kevin Nash
Keywords(s):
Animal Models
,
Medical Therapeutics Gene Therapy
,
Neurodegenerative Diseases
,
Neuroscience
Category(s):
Technology Classifications > Medical > Biomedical Engineering
,
Technology Classifications > Medical > Neuroscience
UBE3A Gene Therapy for the Treatment of Tauopathies
Advantages: Reduction in Pathology Improved Memory and Cognitive Function Targeted Delivery and Brain-wide Distribution Business Summary: Alzheimer’s disease (AD) is a neurodegenerative disease that involves the accumulation of A-Beta proteins and Tau proteins within the brain and leads to cognitive impairments. The accumulation of these...
Published: 9/26/2023
|
Inventor(s):
Jazmin Pena
,
Kevin Nash
Keywords(s):
Medical Diagnostics
,
Neurodegenerative Diseases
,
Neuroscience
,
Therapeutics
Category(s):
Technology Classifications > Medical
,
Technology Classifications > Medical > Neuroscience
,
Technology Classifications > Medical > Biomedical Engineering
,
Technology Classifications > Medical > Biotechnology
,
Technology Classifications > Medical > Medical Diagnostics
,
Technology Classifications > Medical > Therapeutics
Countering Fragile X Syndrome with Reelin
Advantages: Precision Targeting Minimized Side Effects Durability Business Summary: Reelin in Fragile X Syndrome presents a novel and innovative strategy for addressing Fragile X Syndrome (FXS), a common inherited intellectual disability. This study is distinguished by its meticulous analysis of the distinctions between pre- and post-synaptic...
Published: 8/22/2024
|
Inventor(s):
Nicole Morrill
,
Kevin Nash
Keywords(s):
Biotechnology
,
Genetics
,
Health Tech
,
Medical Diagnostics
Category(s):
Technology Classifications > Medical
,
Technology Classifications > Medical > Neuroscience
,
Technology Classifications > Medical > Therapeutics
,
Technology Classifications > Medical > Biotechnology
,
Technology Classifications > Medical > Medical Diagnostics